相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
Edward K. Duran et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population
Anette Varbo et al.
ANNALS OF NEUROLOGY (2019)
Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL
Yuki Fujihara et al.
CIRCULATION JOURNAL (2019)
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
J. L. Witztum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137895 Individuals
Anders B. Wulff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
Antonio J. Vallejo-Vaz et al.
CIRCULATION (2018)
Remnant-like particles and coronary artery disease in familial hypercholesterolemia
Hayato Tada et al.
CLINICA CHIMICA ACTA (2018)
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
Anum Saeed et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease
Si Van Nguyen et al.
JOURNAL OF CARDIOLOGY (2017)
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
F. E. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol
Patrick R. Lawler et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease
Anne-Marie K. Jepsen et al.
CLINICAL CHEMISTRY (2016)
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
Jan Boren et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
Parag H. Joshi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population
Anette Varbo et al.
CLINICAL CHEMISTRY (2015)
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
Anette Varbo et al.
CIRCULATION (2013)
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
Anders Berg Jorgensen et al.
EUROPEAN HEART JOURNAL (2013)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Regulation of triglyceride metabolism by Angiopoietin-like proteins
Frits Mattijssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals
Takamitsu Nakamura et al.
ATHEROSCLEROSIS (2011)
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
Allan D. Sniderman et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation
Limin Wang et al.
JOURNAL OF LIPID RESEARCH (2009)
The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma
K Nakajima et al.
CLINICA CHIMICA ACTA (2006)
Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with β-quantification in a large population
AJ Tremblay et al.
CLINICAL BIOCHEMISTRY (2004)
Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication
T Wang et al.
ATHEROSCLEROSIS (2003)
Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study
JR McNamara et al.
ATHEROSCLEROSIS (2001)
分享论文
